A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.
| Image |  |
|---|---|
| Description | scientific article published on 19 May 2017 |
| Author/s |
author: Carmen Guillen Ponce Richard A Hubner Naureen Starling |
| Publication date | May 19, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |